Press releases
- Press releases
- Browse
Press releases
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
An HIV/AIDS vaccine developed by University of Western Ontario professor Chil-Yong Kang has reached "an important milestone" as it pushes towards the first phase of human trials. More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
An HIV/AIDS vaccine developed at The University of Western Ontario is set for the first phase of human trials.
Sumagen Canada today announced it has submitted an Investigational New Drug application to the United States FDA. More
Sumagen Canada today announced it has submitted an Investigational New Drug application to the United States FDA. More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing More
With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report More
Robarts Clinical Trials at The University of Western Ontario has been awarded a $4.7 million grant to conduct a randomized controlled trial evaluating treatment options for Crohn's disease. More
Science Minister, David Willetts, and Health Minister, Lord Howe, have announced that King’s College London will be one of nine universities involved in a world-first initiative to deliver new treatments and medicines to patients faster. More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 15 pages - $250
Dec 2010 - 37 pages - $500
Jan 2010 - $75
Jan 2011 - 34 pages - $500
May 2011 - 15 pages - $250
Nov 2010 - 40 pages - $500
Apr 2011 - 75 pages - $3,800
Dec 2010 - 22 pages - $500
Oct 2011 - 113 pages - $2,795
May 2011 - 25 pages - $250
Your selection
Browse By
- Industry sector
- Animal health
- Biotech
- Diagnostic
- Drug delivery
- Medical device
- Pharmaceutical
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us